论文部分内容阅读
目的:研究康妇炎灌肠疗法与盆腔炎治疗仪联用对于盆腔炎导致的慢性疼痛症状的临床综合效果。方法:采取随机抽样的方法选择2014年6月至2016年6月在平塘县人民医院就诊的盆腔炎患者共有100例,将其平均分成两个组,即单纯组以及联合组。其中,单纯组的患者实施盆腔炎治疗仪的治疗方法,而联合组的患者在盆腔炎治疗仪的基础上增加了康妇炎灌肠疗法,在治疗完成后比较分析两组患者的疼痛评分。结果:在治疗前,两组患者的疼痛分值没有统计学意义(P>0.05),在治疗后两组患者的疼痛分值比治疗前更优异,组内差异具有统计学意义(P<0.05)。联合组患者疼痛症状的改善时间以及疼痛分值都比单纯组患者更优异,组间比较差异具有统计学意义(P<0.05)。两组患者都没有出现严重的药物过敏反应以及其他副作用。结论:康妇炎灌肠疗法与盆腔炎治疗仪联用对于盆腔炎导致的慢性疼痛症状的综合效果优异,能够显著减轻患者的疼痛症状,提高了患者的生活质量。
Objective: To study the clinical effect of combination of Kangfuyan enema therapy and pelvic inflammatory disease treatment instrument on chronic pain symptom caused by pelvic inflammatory disease. METHODS: A total of 100 patients with pelvic inflammatory disease were selected from the People’s Hospital of Pingtang County from June 2014 to June 2016 by random sampling. They were divided equally into two groups, namely the simple group and the combined group. Among them, the simple group of patients treated with pelvic inflammatory disease treatment, and the combined group of patients in the pelvic inflammatory disease treatment instrument based on the increase of Kang Fu Yan enema therapy, the treatment was completed after a comparative analysis of two groups of patients with pain score. Results: Before treatment, pain scores of the two groups were not statistically significant (P> 0.05). After treatment, pain scores of the two groups were better than before treatment, and the difference was statistically significant (P <0.05 ). Patients in the combined group had better pain symptom improvement scores and pain scores than patients in the simple group, with significant differences between the two groups (P <0.05). No serious allergic reactions to the drug and other side effects occurred in both groups. Conclusion: The combination of Kangfuyan enema therapy and pelvic inflammatory disease therapeutic device is superior to the comprehensive effect of chronic pain symptom caused by pelvic inflammatory disease, and can significantly reduce the patient’s pain symptoms and improve the quality of life of patients.